GHRS
Gh Research Plc
NASDAQ · Pharmaceuticals
$15.17
+1.51 (+11.02%)
Open$13.96
Previous Close$13.66
Day High$15.19
Day Low$13.96
52W High$19.51
52W Low$7.98
Volume—
Avg Volume232.0K
Market Cap940.68M
P/E Ratio—
EPS$-0.73
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+218.0% upside
Current
$15.17
$15.17
Target
$48.23
$48.23
$34.28
$48.23 avg
$66.93
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 289.57M | 263.52M | 305.92M |
| Net Income | 46.13M | 45.80M | 47.46M |
| Profit Margin | 15.9% | 17.4% | 15.5% |
| EBITDA | 85.32M | 72.54M | 88.44M |
| Free Cash Flow | 28.26M | 23.23M | 28.03M |
| Rev Growth | +11.0% | +19.2% | +2.7% |
| Debt/Equity | 0.68 | 0.55 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |